A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of VX-661 in Combination With Ivacaftor
Clinical trial NCT02347657 · COMPLETED
Trial details
- NCT number
- NCT02347657
- Sponsor
- Vertex Pharmaceuticals Incorporated
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-01-01
- Primary completion
- 2017-01-20
- Enrollment
- 510
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.